Literature DB >> 18471073

Functional properties of alpha7 nicotinic acetylcholine receptors co-expressed with RIC-3 in a stable recombinant CHO-K1 cell line.

Renza Roncarati1, Tamara Seredenina, Brian Jow, Flora Jow, Silvia Papini, Angela Kramer, Hendrick Bothmann, John Dunlop, Georg C Terstappen.   

Abstract

Heterologous functional expression of alpha7 nicotinic acetylcholine receptors (nAChRs) is difficult to achieve in mammalian cell lines, and the reasons have been associated with a lack of expression of the putative chaperone factor RIC-3. Here, we describe the generation and functional and pharmacological characterization of a Chinese hamster ovary (CHO)-K1 cell line co-expressing the human alpha7 nAChR and RIC-3. Stable recombinant cells expressing alpha7 nAChR on the plasma membrane were selected by binding of fluorochrome-conjugated alpha-bungarotoxin and fluorescence-activated cell sorting. The presence of functional alpha7 channels was demonstrated by whole cell patch clamp recordings. Nicotine and acetylcholine induced rapid desensitizing currents with 50% effective concentration values of 14 and 37 microM, respectively, with agonist-evoked currents detected in approximately 75% of the cell population. Surprisingly, when tested in a FLIPR (Molecular Devices, Sunnyvale, CA) Ca(2+) assay, activation of alpha7 nAChRs was measured only when nicotinic agonists were applied either in the presence of the positive allosteric modulator (PAM) PNU-120596 or after pretreatment of cells with the tyrosine kinase inhibitor genistein. No Ca(2+) influx was measured upon addition of agonists alone or together with allosteric potentiators such as 5-hydroxyindole that predominantly increase the apparent peak amplitude without robustly affecting the current desensitization rate, as exemplified by PNU-120596. These results show that functional alpha7 nAChRs can stably be expressed in the non-neuronal CHO-K1 cell line. This recombinant cell system is useful for characterization of alpha7 nAChRs and to study the mechanism of action of chemical modulators, in particular the detection of PAMs capable of slowing receptor desensitization kinetics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18471073     DOI: 10.1089/adt.2007.120

Source DB:  PubMed          Journal:  Assay Drug Dev Technol        ISSN: 1540-658X            Impact factor:   1.738


  18 in total

Review 1.  Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: advantages and limitations.

Authors:  Dustin K Williams; Jingyi Wang; Roger L Papke
Journal:  Biochem Pharmacol       Date:  2011-05-14       Impact factor: 5.858

2.  Direct interaction of the resistance to inhibitors of cholinesterase type 3 protein with the serotonin receptor type 3A intracellular domain.

Authors:  Sita Nirupama Nishtala; Nelli Mnatsakanyan; Akash Pandhare; Chun Leung; Michaela Jansen
Journal:  J Neurochem       Date:  2016-03-11       Impact factor: 5.372

Review 3.  α7 nicotinic ACh receptors as a ligand-gated source of Ca(2+) ions: the search for a Ca(2+) optimum.

Authors:  Victor V Uteshev
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

4.  Activation of functional α7-containing nAChRs in hippocampal CA1 pyramidal neurons by physiological levels of choline in the presence of PNU-120596.

Authors:  Bopanna I Kalappa; Alexander G Gusev; Victor V Uteshev
Journal:  PLoS One       Date:  2010-11-12       Impact factor: 3.240

5.  Effects of α7 positive allosteric modulators in murine inflammatory and chronic neuropathic pain models.

Authors:  Kelen Freitas; Sudeshna Ghosh; F Ivy Carroll; Aron H Lichtman; M Imad Damaj
Journal:  Neuropharmacology       Date:  2012-10-16       Impact factor: 5.250

6.  Ric-3 chaperone-mediated stable cell-surface expression of the neuronal alpha7 nicotinic acetylcholine receptor in mammalian cells.

Authors:  Ana Sofía Vallés; Ana M Roccamo; Francisco J Barrantes
Journal:  Acta Pharmacol Sin       Date:  2009-06       Impact factor: 6.150

7.  Physiological concentrations of choline activate native alpha7-containing nicotinic acetylcholine receptors in the presence of PNU-120596 [1-(5-chloro-2,4-dimethoxyphenyl)-3-(5-methylisoxazol-3-yl)-urea].

Authors:  Alexander G Gusev; Victor V Uteshev
Journal:  J Pharmacol Exp Ther       Date:  2009-11-18       Impact factor: 4.030

8.  Electrophysiology-Based Assays to Detect Subtype-Selective Modulation of Human Nicotinic Acetylcholine Receptors.

Authors:  Glenn E Kirsch; Nikolai B Fedorov; Yuri A Kuryshev; Zhiqi Liu; Lucas C Armstrong; Michael S Orr
Journal:  Assay Drug Dev Technol       Date:  2016-08       Impact factor: 1.738

9.  Xenopus laevis RIC-3 enhances the functional expression of the C. elegans homomeric nicotinic receptor, ACR-16, in Xenopus oocytes.

Authors:  Hayley M Bennett; Kristin Lees; Kate M Harper; Andrew K Jones; David B Sattelle; Susan Wonnacott; Adrian J Wolstenholme
Journal:  J Neurochem       Date:  2012-10-10       Impact factor: 5.372

10.  Chemical chaperones exceed the chaperone effects of RIC-3 in promoting assembly of functional α7 AChRs.

Authors:  Alexander Kuryatov; Jayanta Mukherjee; Jon Lindstrom
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.